Colgate-Palmolive Aktie 919477 / US1941621039
94.90
USD
0.65
USD
0.69%
22.11.2024
BTT
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Orderbuch | Analysen | |||||
| Historisch | ||||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
Colgate-Palmolive Dividenden Kalender
| Datum | Name | Rendite * | Dividende | Währung |
|---|---|---|---|---|
| 2023 | Colgate-Palmolive Co. | 2.40 | 1.91 | USD |
| 2022 | Colgate-Palmolive Co. | 2.36 | 1.86 | USD |
| 2021 | Colgate-Palmolive Co. | 2.10 | 1.79 | USD |
| 2020 | Colgate-Palmolive Co. | 2.05 | 1.75 | USD |
| 2019 | Colgate-Palmolive Co. | 2.48 | 1.71 | USD |
| 2018 | Colgate-Palmolive Co. | 2.79 | 1.66 | USD |
| 2017 | Colgate-Palmolive Co. | 2.11 | 1.59 | USD |
| 2016 | Colgate-Palmolive Co. | 2.37 | 1.55 | USD |
| 2015 | Colgate-Palmolive Co. | 2.25 | 1.50 | USD |
| 2014 | Colgate-Palmolive Co. | 2.05 | 1.42 | USD |
Gewinn je Aktie- Colgate-Palmolive
| 2.3 17 | 2.8 18 | 2.8 19 | 3.1 20 | 2.6 21 | 2.1 22 | 2.8 23 |
Umsatz je Aktie- Colgate-Palmolive
| 17.4 17 | 17.8 18 | 18.2 19 | 19.2 20 | 20.5 21 | 21.4 22 | 23.5 23 |
KGV- Colgate-Palmolive
| 33.1 17 | 21.7 18 | 25.0 19 | 27.3 20 | 33.4 21 | 37.0 22 | 28.7 23 |
Colgate-Palmolive Co.: Die Aktie (in USD)
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie berichtet | 2.28 | 2.75 | 2.75 | 3.14 | 2.55 | 2.13 | 2.77 |
| Gewinn je Aktie unverwässert | 2.30 | 2.76 | 2.76 | 3.15 | 2.56 | 2.13 | 2.78 |
| Gewinn je Aktie verwässert | 2.28 | 2.75 | 2.75 | 3.14 | 2.55 | 2.13 | 2.77 |
| Dividende pro Aktie | 1.59 | 1.66 | 1.71 | 1.75 | 1.79 | 1.86 | 1.91 |
| Gesamtdividendenausschüttung in Mio. | 1’405.00 | 1’448.00 | 1’473.00 | 1’502.00 | 1’513.00 | 1’556.00 | 1’579.00 |
Colgate-Palmolive Co.: Unternehmenskennzahlen (in USD)
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Umsatz je Aktie | 17.41 | 17.81 | 18.22 | 19.17 | 20.54 | 21.42 | 23.46 |
| KGV (Jahresendkurs, EPS unverwässert) | 33.10 | 21.65 | 25.04 | 27.26 | 33.42 | 37.03 | 28.74 |
| KGV (Jahresendkurs, EPS verwässert) | 33.10 | 21.65 | 25.04 | 27.26 | 33.42 | 37.03 | 28.74 |
| KGV (Jahresendkurs) | 33.10 | 21.65 | 25.04 | 27.26 | 33.42 | 37.03 | 28.74 |
| Dividendenrendite Jahresende in % | 2.11 | 2.79 | 2.48 | 2.05 | 2.10 | 2.36 | 2.40 |
| Eigenkapitalquote in % | 1.92 | 1.62 | 3.71 | 6.92 | 6.46 | 5.12 | 5.84 |
| Fremdkapitalquote in % | 98.08 | 98.38 | 96.29 | 93.08 | 93.54 | 94.88 | 94.16 |
Colgate-Palmolive Co.: GuV (in Mio. USD)
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Umsatzerlöse | 15’454.00 | 15’544.00 | 15’693.00 | 16’471.00 | 17’421.00 | 17’967.00 | 19’457.00 |
| Umsatzveränderung in % | 1.70 | 0.58 | 0.96 | 4.96 | 5.77 | 3.13 | 8.29 |
| Bruttoergebnis vom Umsatz | 9’323.00 | 9’206.00 | 9’277.00 | 9’933.00 | 10’293.00 | 10’150.00 | 11’251.00 |
| Bruttoergebnisveränderung in % | 2.09 | -1.25 | 0.77 | 7.07 | 3.62 | -1.39 | 10.85 |
| Operatives Ergebnis | 3’915.00 | 3’850.00 | 3’762.00 | 3’911.00 | 3’886.00 | 3’585.00 | 4’131.00 |
| Veränderung Operatives Ergebnis in % | -1.14 | -1.66 | -2.29 | 3.96 | -0.64 | -7.75 | 15.23 |
| Ergebnis vor Steuern | 3’487.00 | 3’464.00 | 3’301.00 | 3’647.00 | 3’087.00 | 2’660.00 | 3’392.00 |
| Veränderung Ergebnis vor Steuern in % | -6.71 | -0.66 | -4.71 | 10.48 | -15.36 | -13.83 | 27.52 |
| Ergebnis nach Steuer | 2’024.00 | 2’400.00 | 2’367.00 | 2’695.00 | 2’166.00 | 1’785.00 | 2’300.00 |
| Veränderung Ergebnis nach Steuer in % | -17.08 | 18.58 | -1.38 | 13.86 | -19.63 | -17.59 | 28.85 |
Colgate-Palmolive Co.: Bilanz (in Mio. USD)
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Gesamtverbindlichkeiten | 12’433 | 11’964 | 14’476 | 14’819 | 14’069 | 14’925 | 15’436 |
| Langzeit Gesamtverbindlichk. pro Aktie | 10.32 | 9.99 | 12.21 | 12.25 | 11.92 | 13.15 | 13.02 |
| Eigenkapital | 243 | 197 | 558 | 1’101 | 971 | 806 | 957 |
| Veränderung Eigenkapital in % | 75.31 | -70.00 | - | 535.04 | -18.03 | -34.15 | 51.87 |
| Bilanzsumme | 12’676 | 12’161 | 15’034 | 15’920 | 15’040 | 15’731 | 16’393 |
| Veränderung Bilanzsumme in % | 4.56 | -4.06 | 23.62 | 5.89 | -5.53 | 4.59 | 4.21 |
Colgate-Palmolive Co.: Sonstige Angaben (in USD)
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie (unverwässert) | 2.30 | 2.76 | 2.76 | 3.15 | 2.56 | 2.13 | 2.78 |
| Veränderung Gewinn je Aktie (unverwässert) in % | -16.23 | 20.10 | -0.05 | 14.16 | -18.51 | -16.74 | 30.25 |
| Gewinn je Aktie (verwässert) | 2.28 | 2.75 | 2.75 | 3.14 | 2.55 | 2.13 | 2.77 |
| Veränderung Gewinn je Aktie (verwässert) in % | -16.18 | 20.59 | -0.01 | 14.10 | -18.59 | -16.66 | 30.35 |
| Anzahl Mitarbeiter | 35’900 | 34’500 | 34’300 | 34’200 | 33’800 | 33’800 | 34’000 |
| Veränderung Anzahl Mitarbeiter in % | -2.18 | -3.90 | -0.58 | -0.29 | -1.17 | 0.00 | 0.59 |
Colgate-Palmolive Co. Termine
| Unternehmen | Event | Datum |
|---|---|---|
| Colgate-Palmolive Co. | Quartalszahlen | 31.01.2025 |
| Colgate-Palmolive Co. | Quartalszahlen | 25.04.2025 |
| Colgate-Palmolive Co. | Quartalszahlen | 25.07.2025 |
| Colgate-Palmolive Co. | Quartalszahlen | 24.10.2025 |
| Colgate-Palmolive Co. | Quartalszahlen | 23.01.2026 |
Colgate-Palmolive Co. vergangene Termine
| Terminart | Info | Datum |
|---|---|---|
| Quartalszahlen | Q3 2024 Earnings Release | 25.10.2024 |
| Quartalszahlen | Q2 2024 Earnings Release | 26.07.2024 |
| Hauptversammlung | Annual General Meeting | 10.05.2024 |
| Quartalszahlen | Q1 2024 Earnings Release | 26.04.2024 |
| Quartalszahlen | Q4 2023 Earnings Release | 26.01.2024 |
| Quartalszahlen | Q3 2023 Earnings Release | 27.10.2023 |
| Quartalszahlen | Q2 2023 Earnings Release | 28.07.2023 |
| Hauptversammlung | Annual General Meeting | 12.05.2023 |
| Quartalszahlen | Q1 2023 Earnings Release | 28.04.2023 |
| Quartalszahlen | Q4 2022 Earnings Release | 27.01.2023 |
| Quartalszahlen | Q3 2022 Earnings Release | 28.10.2022 |
| Quartalszahlen | Q2 2022 Earnings Release | 29.07.2022 |
| Hauptversammlung | Annual General Meeting | 06.05.2022 |
| Quartalszahlen | Q1 2022 Earnings Release | 29.04.2022 |
| Quartalszahlen | Q4 2021 Earnings Release | 28.01.2022 |
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 99.88 |
| The Vanguard Group, Inc. | 9.78 |
| Vanguard Group, Inc. (Subfiler) | 9.42 |
| State Street Corp. | 5.93 |
| SSgA Funds Management, Inc. | 5.83 |
| T Rowe Price Associates, Inc. (13F Subfiler) | 3.64 |
| Vanguard Total Stock Market ETF | 3.16 |
| BlackRock Fund Advisors | 2.73 |
| Vanguard 500 Index Fund | 2.65 |
| Geode Capital Management LLC | 2.47 |
| BlackRock Institutional Trust Co. NA | 2.28 |
| Wellington Management Co. LLP (Wellington Breakout) | 1.79 |
| Third Point LLC | 1.35 |
| Vanguard Dividend Growth Fund | 1.29 |
| Fidelity 500 Index Fund | 1.23 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 34’300 | 34’200 | 33’800 | 33’800 | 34’000 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0.46 | 0.48 | 0.52 | 0.53 | 0.57 |
Bilanz (in Mio. USD) - Aktiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 4’179 | 4’338 | 4’397 | 5’113 | 5’279 |
| Summe Anlagevermögen | 10’855 | 11’582 | 10’643 | 10’618 | 11’114 |
| Summe Aktiva | 15’034 | 15’920 | 15’040 | 15’731 | 16’393 |
Bilanz (in Mio. USD) - Passiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Gesamtverschuldung/ -verbindlichkeiten | 8’483 | 8’214 | 7’833 | 9’271 | 9’064 |
| Summe Fremdkapital | 14’476 | 14’819 | 14’069 | 14’925 | 15’436 |
| Summe Eigenkapital | 558 | 1’101 | 971 | 806 | 957 |
| Summe Passiva | 15’034 | 15’920 | 15’040 | 15’731 | 16’393 |
Adresse
| 300 Park Avenue, 10022-7499 New York | |
| Telefon | +1 (212) 310-2000 |
| URL | http://www.colgatepalmolive.com |
Management
|
Al Lee
Chief Internal Governance Officer |
|
Alain Semeneri
VP & GM-Hill's Pet Nutrition-Europe, Middle East |
|
Angel Dario Belalcazar
Vice President-Global Research & Development |
|
Ann Tracy
Chief Sustainability Officer |
|
Betsy Floman Fishbone
EVP, Senior Associates-GC, HR Lit Comp & NA Ops |
|
Bill van de Graaf
Vice President-Colgate North America |
|
Brent Peterson
Vice President-Global Human Resources |
|
Brian O. Newman
Independent Director |
|
Brigitte H. King
Global Chief Digital Officer |
|
C. Martin Harris
Independent Director |
|
Clifford E. Wilkins
EVP, Senior Association-GC, Technology & Reg |
|
David Foster
Chief Information Officer |
|
Derek Gordon
VP & Chief Diversity, Equity & Inclusion Officer |
|
Eugene Kelly
VP-Global Diversity, Equity & Inclusion |
|
Eutychus Karuru
Senior Vice President-Audit |
|
Gillian Barclay
SVP-Global Public Health & Scientific Affairs |
|
Gina Grant
Treasurer & Senior Vice President |
|
Gregory Malcolm
Executive Vice President & Controller |
|
Javier Llinas
Senior Vice President-Infrastructure & Operations |
|
Jennifer M. Daniels
Secretary & Chief Legal Officer |
|
John Faucher
Chief Investor Relations Officer & Executive VP |
|
John P. Bilbrey
Independent Director |
|
John T. Cahill
Independent Director |
|
John W. Kooyman
Chief of Staff |
|
Josue M. Muñoz
Vice President-Global Supply Chain |
|
Kim Faulkner
Chief Ethics & Compliance Officer |
|
Kimberly A. Nelson
Independent Director |
|
Lia Arvanitidou
Senior Vice President-Skin Health, PC, HC, R&D |
|
Linda Topping
Vice President-Global Supply Chain |
|
Lisa M. Edwards
Independent Director |
|
Lorrie M. Norrington
Lead Independent Director |
|
Martin J. Collins
EVP-Global Total Rewards & HR Operations |
|
Martina T. Hund-Mejean
Independent Director |
|
Nadine P. Flynn
Executive VP, Senior Associates-GC & Marketing |
|
Noel R. Wallace
Chairman, President & Chief Executive Officer |
|
Panagiotis Tsourapas
Group President-Europe & Developing Markets |
|
Paul Kevin McGarry
Vice President-Global Information Technology |
|
Philip Durocher
Vice President-North America |
|
Phillip G. Shotts
Senior Vice President-Finance |
|
Prabha Parameswaran
Group President-Growth & Strategy |
|
Raj Kohli
Vice President-Global Research & Development |
|
Ram Raghavan
President-Enterprise Oral Care |
|
Riccardo Ricci
Vice President & General Manager-Brazil |
|
Sally Massey
Chief Human Resources Officer |
|
Scott Cain
Executive Vice President-Global Taxation |
|
Scott Campbell
Vice President-Global Marketing |
|
Stanley J. Sutula
Chief Financial Officer |
|
Stephan Habif
Chief Technology Officer |
|
Steven A. Cahillane
Independent Director |
|
Taylor Gordy
VP & General Manager-Colgate Northern Europe |
|
Wojciech Krol
VP & General Manager-Central Europe East |